
11.21 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 6.88 Today|||52-Week Range 22.87 | +21.45% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $470.2M |
Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford Massachusetts 01730 |
Edward M. Kaye | Chief Executive Officer & Director |
Huw M. Nash | Chief Operating & Business Officer |
Stephen J. Tulipano | Chief Financial Officer |
Barry S. Ticho | Chief Medical Officer |
Isabel Aznarez | Group Vice President-Discovery Research |